Cargando…

Recent Advances in treatment of urethral stricture disease in men

Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangir, Naside, Chapple, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202089/
https://www.ncbi.nlm.nih.gov/pubmed/32419925
http://dx.doi.org/10.12688/f1000research.21957.1
_version_ 1783529668354244608
author Mangir, Naside
Chapple, Christopher
author_facet Mangir, Naside
Chapple, Christopher
author_sort Mangir, Naside
collection PubMed
description Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medicine and tissue engineering. Research efforts have primarily focused on decreasing the recurrence of stricture after internal urethrotomy and constructing tissue-engineered urethral substitutes to improve clinical outcomes of urethroplasty surgeries. The aim of this article is to review the most recent advancements in the management of urethral stricture disease in men.
format Online
Article
Text
id pubmed-7202089
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-72020892020-05-14 Recent Advances in treatment of urethral stricture disease in men Mangir, Naside Chapple, Christopher F1000Res Review Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medicine and tissue engineering. Research efforts have primarily focused on decreasing the recurrence of stricture after internal urethrotomy and constructing tissue-engineered urethral substitutes to improve clinical outcomes of urethroplasty surgeries. The aim of this article is to review the most recent advancements in the management of urethral stricture disease in men. F1000 Research Limited 2020-05-05 /pmc/articles/PMC7202089/ /pubmed/32419925 http://dx.doi.org/10.12688/f1000research.21957.1 Text en Copyright: © 2020 Mangir N and Chapple C http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Mangir, Naside
Chapple, Christopher
Recent Advances in treatment of urethral stricture disease in men
title Recent Advances in treatment of urethral stricture disease in men
title_full Recent Advances in treatment of urethral stricture disease in men
title_fullStr Recent Advances in treatment of urethral stricture disease in men
title_full_unstemmed Recent Advances in treatment of urethral stricture disease in men
title_short Recent Advances in treatment of urethral stricture disease in men
title_sort recent advances in treatment of urethral stricture disease in men
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202089/
https://www.ncbi.nlm.nih.gov/pubmed/32419925
http://dx.doi.org/10.12688/f1000research.21957.1
work_keys_str_mv AT mangirnaside recentadvancesintreatmentofurethralstricturediseaseinmen
AT chapplechristopher recentadvancesintreatmentofurethralstricturediseaseinmen